Cavalcante-Silva Luiz Henrique Agra, Leite Ericka Garcia, Almeida Fernanda Silva, Andrade Arthur Gomes de, Comberlang Fernando Cézar, Lucena Cintya Karina Rolim, Pachá Anna Stella Cysneiros, Csordas Bárbara Guimarães, Keesen Tatjana S L
Immunology of Infectious Diseases Laboratory, Department of Cellular and Molecular Biology, Federal University of Paraiba, João Pessoa 58051-900, PB, Brazil.
Infectious and Contagious Disease Complex Dr. Clementino Fraga, João Pessoa 58015-270, PB, Brazil.
Microorganisms. 2023 Nov 19;11(11):2810. doi: 10.3390/microorganisms11112810.
Many studies have focused on SARS-CoV-2 and () co-infection consequences. However, after a vaccination plan against COVID-19, the cases of severe disease and death are consistently controlled, although cases of asymptomatic and mild COVID-19 still happen together with tuberculosis (TB) cases. Thus, in this context, we sought to compare the T cell response of COVID-19-non-vaccinated and -vaccinated patients with active tuberculosis exposed to SARS-CoV-2 antigens. Flow cytometry was used to analyze activation markers (i.e., CD69 and CD137) and cytokines (IFN-γ, TNFα, IL-17, and IL-10) levels in CD4 and CD8 T cells upon exposure to SARS-CoV-2 peptides. The data obtained showed that CD8 T cells from non-vaccinated TB patients present a high frequency of CD69 and TNF-α after viral challenge compared to vaccinated TB donors. Conversely, CD4 T cells from vaccinated TB patients show a high frequency of IL-10 after spike peptide stimulus compared to non-vaccinated patients. No differences were observed in the other parameters analyzed. The results suggest that this reduced immune balance in coinfected individuals may have consequences for pathogen control, necessitating further research to understand its impact on clinical outcomes after COVID-19 vaccination in those with concurrent SARS-CoV-2 and infections.
许多研究都聚焦于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与()合并感染的后果。然而,在实施针对2019冠状病毒病(COVID-19)的疫苗接种计划后,重症和死亡病例得到了持续控制,尽管无症状和轻症COVID-19病例仍与结核病(TB)病例同时出现。因此,在此背景下,我们试图比较未接种和接种COVID-19疫苗的活动性结核病患者接触SARS-CoV-2抗原后的T细胞反应。采用流式细胞术分析接触SARS-CoV-2肽后CD4和CD8 T细胞中的活化标志物(即CD69和CD137)以及细胞因子(干扰素-γ、肿瘤坏死因子α、白细胞介素-17和白细胞介素-10)水平。获得的数据显示,与接种疫苗的结核病供体相比,未接种疫苗的结核病患者的CD8 T细胞在病毒攻击后呈现出高频率的CD69和肿瘤坏死因子-α。相反,与未接种疫苗的患者相比,接种疫苗的结核病患者的CD4 T细胞在刺突肽刺激后呈现出高频率的白细胞介素-10。在分析的其他参数中未观察到差异。结果表明,合并感染个体中这种免疫平衡的降低可能对病原体控制产生影响,有必要进一步研究以了解其对同时感染SARS-CoV-2和()的患者在接种COVID-19疫苗后临床结局的影响。